Does TADALAFIL Cause Systemic scleroderma? 25 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Systemic scleroderma have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 0.1% of all adverse event reports for TADALAFIL.
25
Reports of Systemic scleroderma with TADALAFIL
0.1%
of all TADALAFIL reports
11
Deaths
11
Hospitalizations
How Dangerous Is Systemic scleroderma From TADALAFIL?
Of the 25 reports, 11 (44.0%) resulted in death, 11 (44.0%) required hospitalization, and 3 (12.0%) were considered life-threatening.
Is Systemic scleroderma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Systemic scleroderma?
RITUXIMAB (54)
CYCLOPHOSPHAMIDE (53)
MACITENTAN (52)
DOCETAXEL (49)
METHOTREXATE (45)
MYCOPHENOLATE MOFETIL (44)
FLUOROURACIL (34)
SELEXIPAG (34)
TREPROSTINIL (34)
BOSENTAN (30)
Which TADALAFIL Alternatives Have Lower Systemic scleroderma Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR